United States Infectious Diagnostics Market Outlook to 2024

Published : Nov-2017

No. of Pages : 138

order by fax Inquire before Buying request discount

Table of Contents

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6

2 Introduction 9
2.1 What Is This Report About? 9
2.2 Infectious Diagnostics Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 11

3 Infectious Diagnostics Market, United States 16
3.1 Infectious Diagnostics Market, United States, Revenue ($m), 2010-2017 16
3.2 Infectious Diagnostics Market, United States, Revenue ($m), 2017-2024 19
3.2.1 Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), by Segment, 2010-2017 22
3.2.2 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), by Segment, 2010-2017 24
3.2.3 Hepatitis Test Kits Market, United States, Revenue ($m), by Segment, 2010-2017 26
3.2.4 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), by Segment, 2010-2017 28
3.2.5 Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), by Segment, 2010-2017 30
3.2.6 Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), by Segment, 2010-2017 32
3.2.7 Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), by Segment, 2010-2017 34
3.2.8 Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), by Segment, 2010-2017 36
3.2.9 Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), by Segment, 2010-2017 38
3.2.10 Retrovirus Tests Market, United States, Revenue ($m), by Segment, 2010-2017 40
3.2.11 Treponema pallidum Diagnostic Tests Market, United States, Revenue ($m), by Segment, 2010-2017 42
3.2.12 Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), by Segment, 2017-2024 44
3.2.13 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), by Segment, 2017-2024 46
3.2.14 Hepatitis Test Kits Market, United States, Revenue ($m), by Segment, 2017-2024 48
3.2.15 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), by Segment, 2017-2024 50
3.2.16 Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), by Segment, 2017-2024 52
3.2.17 Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), by Segment, 2017-2024 54
3.2.18 Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), by Segment, 2017-2024 56
3.2.19 Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), by Segment, 2017-2024 58
3.2.20 Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), by Segment, 2017-2024 60
3.2.21 Retrovirus Tests Market, United States, Revenue ($m), by Segment, 2017-2024 62
3.2.22 Treponema pallidum Diagnostic Tests Market, United States, Revenue ($m), by Segment, 2017-2024 64
3.3 Infectious Diagnostics Market, United States, Volume (Units), 2010-2017 66
3.4 Infectious Diagnostics Market, United States, Volume (Units), 2017-2024 69
3.4.1 Chlamydia trichomatis Diagnostic Test Kits Market, United States, Volume (Units), by Segment, 2010-2017 72
3.4.2 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Volume (Units), by Segment, 2010-2017 74
3.4.3 Hepatitis Test Kits Market, United States, Volume (Units), by Segment, 2010-2017 76
3.4.4 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Volume (Units), by Segment, 2010-2017 78
3.4.5 Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Volume (Units), by Segment, 2010-2017 80
3.4.6 Infectious Diagnostics Rapid Tests & POC Market, United States, Volume (Units), by Segment, 2010-2017 82
3.4.7 Mycobacterium tuberculosis Diagnostic Tests Market, United States, Volume (Units), by Segment, 2010-2017 84
3.4.8 Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), by Segment, 2010-2017 86
3.4.9 Post Streptococcus pyogenes Diagnostic Tests Market, United States, Volume (Units), by Segment, 2010-2017 88
3.4.10 Retrovirus Tests Market, United States, Volume (Units), by Segment, 2010-2017 90
3.4.11 Treponema pallidum Diagnostic Tests Market, United States, Volume (Units), by Segment, 2010-2017 92
3.4.12 Chlamydia trichomatis Diagnostic Test Kits Market, United States, Volume (Units), by Segment, 2017-2024 94
3.4.13 Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Volume (Units), by Segment, 2017-2024 96
3.4.14 Hepatitis Test Kits Market, United States, Volume (Units), by Segment, 2017-2024 98
3.4.15 Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Volume (Units), by Segment, 2017-2024 100
3.4.16 Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Volume (Units), by Segment, 2017-2024 102
3.4.17 Infectious Diagnostics Rapid Tests & POC Market, United States, Volume (Units), by Segment, 2017-2024 104
3.4.18 Mycobacterium tuberculosis Diagnostic Tests Market, United States, Volume (Units), by Segment, 2017-2024 106
3.4.19 Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), by Segment, 2017-2024 108
3.4.20 Post Streptococcus pyogenes Diagnostic Tests Market, United States, Volume (Units), by Segment, 2017-2024 110
3.4.21 Retrovirus Tests Market, United States, Volume (Units), by Segment, 2017-2024 112
3.4.22 Treponema pallidum Diagnostic Tests Market, United States, Volume (Units), by Segment, 2017-2024 114
3.5 Infectious Diagnostics Market, United States, Average Price ($), 2010-2024 116
3.6 Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), 2017 122
3.7 Infectious Diagnostics Market, United States, Company Share by Revenue ($m), 2017 123

4 Overview of Key Companies in United States, Infectious Diagnostics Market 125
4.1 F. Hoffmann-La Roche Ltd 125
4.1.1 Company Overview 125
4.2 Abbott Laboratories 125
4.2.1 Company Overview 125
4.3 Hologic Inc 125
4.3.1 Company Overview 125
4.4 Alere Inc 126
4.4.1 Company Overview 126
4.5 Bio-Rad Laboratories Inc 126
4.5.1 Company Overview 126
4.6 Qiagen NV 126
4.6.1 Company Overview 126
4.7 Beckman Coulter Inc 126
4.7.1 Company Overview 126
4.8 Siemens Healthcare GmbH 127
4.8.1 Company Overview 127
4.9 DiaSorin S.p.A 127
4.9.1 Company Overview 127
4.10 Becton Dickinson and Co 127
4.10.1 Company Overview 127
4.11 Cepheid 127
4.11.1 Company Overview 127
4.12 Thermo Fisher Scientific Inc 128
4.12.1 Company Overview 128
4.13 bioMerieux SA 128
4.13.1 Company Overview 128

5 Infectious Diagnostics Market Pipeline Products 129

6 Appendix 132
6.1 Research Methodology 133
6.1.1 Coverage 133
6.1.2 Secondary Research 133
6.1.3 Primary Research 134
6.1.4 Market Modeling and Forecasting 135
6.1.5 Company Share Analysis 136
6.1.6 Distribution Share Analysis 137
6.1.7 Benchmarking 137
6.2 GlobalData Consulting 137
6.3 Contact Us 138
6.4 Disclaimer 138

List of Tables

Table 1: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 16
Table 2: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 19
Table 3: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 22
Table 4: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 24
Table 5: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 26
Table 6: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 28
Table 7: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 30
Table 8: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 32
Table 9: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 34
Table 10: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 36
Table 11: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 38
Table 12: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 40
Table 13: Treponema pallidum Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 42
Table 14: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 44
Table 15: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 46
Table 16: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 48
Table 17: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 50
Table 18: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 52
Table 19: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 54
Table 20: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 56
Table 21: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 58
Table 22: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 60
Table 23: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 62
Table 24: Treponema pallidum Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 64
Table 25: Infectious Diagnostics Market, United States, Volume (Units), Historic, 2010-2017 66
Table 26: Infectious Diagnostics Market, United States, Volume (Units), Forecast, 2017-2024 69
Table 27: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Volume (Units), Historic, 2010-2017 72
Table 28: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Volume (Units), Historic, 2010-2017 74
Table 29: Hepatitis Test Kits Market, United States, Volume (Units), Historic, 2010-2017 76
Table 30: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Volume (Units), Historic, 2010-2017 78
Table 31: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Volume (Units), Historic, 2010-2017 80
Table 32: Infectious Diagnostics Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 82
Table 33: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 84
Table 34: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), Historic, 2010-2017 86
Table 35: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 88
Table 36: Retrovirus Tests Market, United States, Volume (Units), Historic, 2010-2017 90
Table 37: Treponema pallidum Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 92
Table 38: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 94
Table 39: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Volume (Units), Forecast, 2017-2024 96
Table 40: Hepatitis Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 98
Table 41: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Volume (Units), Forecast, 2017-2024 100
Table 42: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 102
Table 43: Infectious Diagnostics Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 104
Table 44: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 106
Table 45: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), Forecast, 2017-2024 108
Table 46: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 110
Table 47: Retrovirus Tests Market, United States, Volume (Units), Forecast, 2017-2024 112
Table 48: Treponema pallidum Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 114
Table 49: Infectious Diagnostics Market, United States, Average Price ($) Historic, 2010-2017 115
Table 50: Infectious Diagnostics Market, United States, Average Price ($), Forecast, 2017-2024 118
Table 51: Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 121
Table 52: Infectious Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2017 123
Table 53: Infectious Diagnostics Market Pipeline Products 128
Table 54: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 134

List of Figures

Figure 1: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 15
Figure 2: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 18
Figure 3: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 21
Figure 4: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 23
Figure 5: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 25
Figure 6: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 27
Figure 7: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 29
Figure 8: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 31
Figure 9: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 33
Figure 10: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 35
Figure 11: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 37
Figure 12: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 39
Figure 13: Treponema pallidum Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 41
Figure 14: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 43
Figure 15: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 45
Figure 16: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 47
Figure 17: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 49
Figure 18: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 51
Figure 19: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 53
Figure 20: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 55
Figure 21: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 57
Figure 22: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 59
Figure 23: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 61
Figure 24: Treponema pallidum Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 63
Figure 25: Infectious Diagnostics Market, United States, Volume (Units), Historic, 2010-2017 65
Figure 26: Infectious Diagnostics Market, United States, Volume (Units), Forecast, 2017-2024 68
Figure 27: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Volume (Units), Historic, 2010-2017 71
Figure 28: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Volume (Units), Historic, 2010-2017 73
Figure 29: Hepatitis Test Kits Market, United States, Volume (Units), Historic, 2010-2017 75
Figure 30: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Volume (Units), Historic, 2010-2017 77
Figure 31: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Volume (Units), Historic, 2010-2017 79
Figure 32: Infectious Diagnostics Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 81
Figure 33: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 83
Figure 34: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), Historic, 2010-2017 85
Figure 35: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 87
Figure 36: Retrovirus Tests Market, United States, Volume (Units), Historic, 2010-2017 89
Figure 37: Treponema pallidum Diagnostic Tests Market, United States, Volume (Units), Historic, 2010-2017 91
Figure 38: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 93
Figure 39: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Volume (Units), Forecast, 2017-2024 95
Figure 40: Hepatitis Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 97
Figure 41: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Volume (Units), Forecast, 2017-2024 99
Figure 42: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Volume (Units), Forecast, 2017-2024 101
Figure 43: Infectious Diagnostics Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 103
Figure 44: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 105
Figure 45: Polymerase Chain Reaction (PCR) Systems Market, United States, Volume (Units), Forecast, 2017-2024 107
Figure 46: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 109
Figure 47: Retrovirus Tests Market, United States, Volume (Units), Forecast, 2017-2024 111
Figure 48: Treponema pallidum Diagnostic Tests Market, United States, Volume (Units), Forecast, 2017-2024 113
Figure 49: Infectious Diagnostics Market, United States, Company Share (%) 2017 122

Filed in: Diagnostics

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) – Global Forecast to 2027 “Increasing prevalence of infectious diseases and the rising funding for R&D are driving the overall growth of the infectious disease diagnostics market” The global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR. Market is driven by factors such as indication of infectious diseases, growing trend in POC testing and rising technological advancements. However, an unfavorable reimbursement scenario is expected to limit market growth to a certain extent in the forecasted years. “The reagents, kits, and consumables accounted for the largest market share in the infectious disease diagnostics market, by product & service, during the forecast period” The infectious disease diagnostics......	$4950
In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) – Global Forecast to 2027 “The global in vitro toxicology testing market is projected to grow at a CAGR of 10.8%.” The in vitro toxicology testing market is expected to reach USD 18.6 billion by 2027 from an estimated USD 11.2 billion in 2022, at a CAGR of 10.8%.Factors such as, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the factors to drive the market “The ADME segment is expected to account for the largest market share in 2021.” Based on toxicity endpoints and tests undertaken across all industries, the in vitro toxicity testing market is segmented into genotoxicity; cytotoxicity; ADME; skin irritation, corrosion, & sensitization; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other endp......	$4950
Molecular Diagnostics Market by Product & Service (Reagents, Kits, Instruments), Test Type (Lab, PoC), Technology (PCR, INAAT, NGS, ISH), Application (Infectious, Oncology, Genetic Testing), End User (Diagnostic Labs, Hospitals) – Global Forecast to 2027 “Rising funding for R&D in molecular diagnostics and increasing prevalence of infectious diseases and cancer are driving the overall growth of the molecular diagnostics market” The global molecular diagnostics market is projected to reach USD 30.2 billion by 2027 from USD 23.2 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as the increasing use of PoC diagnostic tests, the rising funding for R&D in molecular diagnostics, the increasing prevalence of infectious diseases and cancer. On the other hand, an unfavorable reimbursement scenario and the high cost of instruments may restrain the growth of this market to a certain extent. “The DNA sequencing & NGS segment accounted for the highest growth rate in the molec......	$4950
Laboratory Proficiency Testing Market by Industry (Clinical Chemistry, Hematology), Food & Animal Feed (Fish, Vegetable), Commercial Beverage (Alcohol), Microbiology, Water, Environmental) by Technology (PCR) – Global Forecast to 2026 “The rising an essential precondition for operational excellence and accreditation in several industries is expected to drive the overall growth of the laboratory proficiency testing market.” The global laboratory proficiency testing market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.4%. With proficiency testing being a mandatory procedure to be undertaken by laboratories functioning in different industries which are under regulation by organizations such as the CLIA, APLAC, and CLSI, the market for proficiency testing is expected to witness significant growth during the forecast period. PT forms an essential precondition for operational excellence and accreditation in several industries. This is one of the major factors driving the gro......	$4950
Liquid Handling System Market by Product (Pipettes, Consumables, Microplate Reagent Dispensers, Liquid Handling Workstations, Burettes, Microplate Washers, Software), Type, Application, End User and Region – Global Forecast to 2026 “The Liquid Handling System market is projected to grow at CAGR of 5.1% from 2021 to 2026” The global liquid handling systems market is expected to reach USD 5.1 billion by 2026 from USD 4.0 billion in 2021, at a CAGR of 5.1% during the forecast period. The growth of this market is majorly driven by industrial growth in the pharma-biotech sector, rising R&D expenditure by biopharma companies, and growing life science research, supported by a favorable funding scenario. However, the slow adoption of automation among small and medium-sized laboratories may restrain the market growth. “Pipettes in the product segment to witness the highest growth during the forecast period.” Based on the products, the global liquid handling system market is segmented into Pipettes, Consum......	$4950
In-Vitro Diagnostics/IVD Market by Product and Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) – Global Forecast to 2026 The global IVD market is projected to reach USD 113.1 billion by 2026 from USD 98.2 billion in 2021, at a CAGR of 2.9% during the forecast period. The growth of the IVD market is mainly driven by the rising geriatric population and the subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated and POC instruments in developed regions, growing awareness regarding diseases diagnosis in developing regions, and growing R&D investments by industry players to launch new IVD products. Also, the development of disease-specific markers and tests is expected to offer potential growth opportunities to market players in the coming years. However, the unfavorable reimbursement scenario is expected to restrain the growth of this market during the f......	$4950
Point of Care & Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy Test), Platform (Microfluidics, Dipsticks), Mode of Purchase (OTC, Prescription), End User (Pharmacy, Hospital, Home) – Global Forecast to 2027 “Dearth of skilled laboratory technicians” The global point of care diagnostics market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. Point-of-care testing (POCT) includes screening or diagnostic tests performed outside traditional laboratories. These tests are designed to be used at or near the site where the patient is located (such as at home, in an ambulance, at a physician’s office, and other locations). POCT allows rapid and reliable diagnostic testing through which outcomes can be obtained instantly, helping physicians/patients to make decisions related to care remotely and as soon as possible. Market growth is mainly driven by the high prevalence of infectious diseases, supportive government p......	$4950
Organ Preservation Market by Solution (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) – Global Forecast to 2026 The organ preservation market is expected to grow at a CAGR of 6.6% in the forecast period. The global organ preservation market is projected to reach USD 317 million by 2026 from USD 270 million in 2021, at a CAGR of 6.6%.Growth in this market is majorly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. However, concerns related to the high cost of organ transplantations and religious concerns in specific geographies are expected to limit the growth of this market to a certain extent. “The University of Wisconsin (UW) holds the largest market share in the solution market.” Based on the Solution, the segment is divided ......	$4950
Medical Refrigerators Market by Type, End Use (Blood Banks, Pharmaceutical Companies, Hospital & Pharmacies, Research Institutes, Medical Laboratories, Diagnostic Centre), & Region(North America, Europe, APAC, MEA, South America) – Global Forecast to 2026 The medical refrigerators market was valued at USD 3.5 Billion in 2020 and is projected to reach USD 4.9 Billion by 2026, at a CAGR of 6.0% during the forecast period. The medical refrigerators market is on course for intense growth across different end use industries such as blood banks, pharmaceutical companies, hospitals, & pharmacies, research institutes, medical laboratories, and diagnostic centers. “The ultra-low temperature freezers segment, by value, is projected to grow at the highest CAGR during the forecast period” By product type, ultra-low temperature freezers segment is expected to grow at the highest CAGR during 2021 to 2026, by value. Ultra-low temperature freezers (ULT freezers) are used for the storage of drugs, enzymes, chemicals, bacteria, viruses, cell pr......	$4950
Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) – Global Forecast to 2026 “Increasing prevalence of infectious diseases and cancer and the rising funding for R&D are driving the overall growth of the point-of-care molecular diagnostics market” The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2% during the forecast period. Market growth is driven by factors such as the increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics and increasing R&D funding, increasing awareness on the early detection of infectious diseases, and the increasing use of POC diagnostic tests. On the other hand, stringent and time-consuming regulatory policies that significantly increase the product launch cycle may challenge market gr......	$4950

United States Infectious Diagnostics Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) – Global Forecast to 2027

In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) – Global Forecast to 2027

Molecular Diagnostics Market by Product & Service (Reagents, Kits, Instruments), Test Type (Lab, PoC), Technology (PCR, INAAT, NGS, ISH), Application (Infectious, Oncology, Genetic Testing), End User (Diagnostic Labs, Hospitals) – Global Forecast to 2027

Laboratory Proficiency Testing Market by Industry (Clinical Chemistry, Hematology), Food & Animal Feed (Fish, Vegetable), Commercial Beverage (Alcohol), Microbiology, Water, Environmental) by Technology (PCR) – Global Forecast to 2026

Liquid Handling System Market by Product (Pipettes, Consumables, Microplate Reagent Dispensers, Liquid Handling Workstations, Burettes, Microplate Washers, Software), Type, Application, End User and Region – Global Forecast to 2026

In-Vitro Diagnostics/IVD Market by Product and Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) – Global Forecast to 2026

Point of Care & Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy Test), Platform (Microfluidics, Dipsticks), Mode of Purchase (OTC, Prescription), End User (Pharmacy, Hospital, Home) – Global Forecast to 2027

Organ Preservation Market by Solution (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) – Global Forecast to 2026

Medical Refrigerators Market by Type, End Use (Blood Banks, Pharmaceutical Companies, Hospital & Pharmacies, Research Institutes, Medical Laboratories, Diagnostic Centre), & Region(North America, Europe, APAC, MEA, South America) – Global Forecast to 2026

Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) – Global Forecast to 2026